Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

335 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Crkl enhances leukemogenesis in BCR/ABL P190 transgenic mice.
Hemmeryckx B, van Wijk A, Reichert A, Kaartinen V, de Jong R, Pattengale PK, Gonzalez-Gomez I, Groffen J, Heisterkamp N. Hemmeryckx B, et al. Among authors: reichert a. Cancer Res. 2001 Feb 15;61(4):1398-405. Cancer Res. 2001. PMID: 11245441
BCR/ABL P190 transgenic mice develop leukemia in the absence of Crkl.
Hemmeryckx B, Reichert A, Watanabe M, Kaartinen V, de Jong R, Pattengale PK, Groffen J, Heisterkamp N. Hemmeryckx B, et al. Among authors: reichert a. Oncogene. 2002 May 9;21(20):3225-31. doi: 10.1038/sj.onc.1205452. Oncogene. 2002. PMID: 12082638
Reduced oncogenicity of p190 Bcr/Abl F-actin-binding domain mutants.
Heisterkamp N, Voncken JW, Senadheera D, Gonzalez-Gomez I, Reichert A, Haataja L, Reinikainen A, Pattengale PK, Groffen J. Heisterkamp N, et al. Among authors: reichert a. Blood. 2000 Sep 15;96(6):2226-32. Blood. 2000. PMID: 10979970 Free article.
Molecular heterogeneity in complete cytogenetic responders after interferon-alpha therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission. German CML Study Group and the UK MRC CML Study Group.
Hochhaus A, Reiter A, Saussele S, Reichert A, Emig M, Kaeda J, Schultheis B, Berger U, Shepherd PC, Allan NC, Hehlmann R, Goldman JM, Cross NC. Hochhaus A, et al. Among authors: reichert a. Blood. 2000 Jan 1;95(1):62-6. Blood. 2000. PMID: 10607685 Free article. Clinical Trial.
335 results